Cell competition in intratumoral and tumor microenvironment interactions

TM Parker, K Gupta, AM Palma, M Yekelchyk… - The EMBO …, 2021 - embopress.org
Tumors are complex cellular and acellular environments within which cancer clones are
under continuous selection pressures. Cancer cells are in a permanent mode of interaction …

[HTML][HTML] DNA binding partners of YAP/TAZ

MK Kim, JW Jang, SC Bae - BMB reports, 2018 - ncbi.nlm.nih.gov
Hippo signaling plays critical roles in regulation of tissue homeostasis, organ size, and
tumorigenesis by inhibiting YES-associated protein (YAP) and PDZ-binding protein TAZ …

Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells

J Feng, H Yang, Y Zhang, H Wei, Z Zhu, B Zhu, M Yang… - Oncogene, 2017 - nature.com
The clinical success of immunotherapy that inhibits the negative immune regulatory pathway
programmed cell death protein 1/PD-1 ligand (PD-1/PD-L1) has initiated a new era in the …

TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer

M Chi, J Liu, C Mei, Y Shi, N Liu, X Jiang, C Liu… - Journal of Experimental …, 2022 - Springer
Background The distant metastasis is the primary cause of cancer morbidity and mortality for
bladder cancer (BLCA) paitents. All the recommended therapy for it largely depends on how …

Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer

J Shen, B Cao, Y Wang, C Ma, Z Zeng, L Liu… - Journal of Experimental …, 2018 - Springer
Background Focal adhesion plays an essential role in tumour invasiveness and metastasis.
Hippo component YAP has been widely reported to be involved in many aspects of tumour …

[HTML][HTML] The novel potent TEAD inhibitor, K-975, inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural …

A Kaneda, T Seike, T Danjo, T Nakajima… - American Journal of …, 2020 - ncbi.nlm.nih.gov
The Hippo signaling pathway regulates cell fate and organ development. In the Hippo
pathway, transcriptional enhanced associate domain (TEAD) which is a transcription factor …

Recent therapeutic approaches to modulate the Hippo pathway in oncology and regenerative medicine

ER Barry, V Simov, I Valtingojer, O Venier - Cells, 2021 - mdpi.com
The Hippo pathway is an evolutionary conserved signaling network that regulates essential
processes such as organ size, cell proliferation, migration, stemness and apoptosis …

Targeting multiple effector pathways in pancreatic ductal adenocarcinoma with a G-quadruplex-binding small molecule

C Marchetti, KG Zyner, SA Ohnmacht… - Journal of medicinal …, 2018 - ACS Publications
Human pancreatic ductal adenocarcinoma (PDAC) involves the dysregulation of multiple
signaling pathways. A novel approach to the treatment of PDAC is described, involving the …

[HTML][HTML] A regulation loop between YAP and NR4A1 balances cell proliferation and apoptosis

L He, L Yuan, W Yu, Y Sun, D Jiang, X Wang, X Feng… - Cell reports, 2020 - cell.com
The Hippo signaling pathway maintains organ size and tissue homeostasis via orchestration
of cell proliferation and apoptosis. How this pathway triggers cell apoptosis remains largely …

LncRNANORAD is repressed by the YAP pathway and suppresses lung and breast cancer metastasis by sequestering S100P

BS Tan, MC Yang, S Singh, YC Chou, HY Chen… - Oncogene, 2019 - nature.com
Metastasis is responsible for most cancer mortality, but its molecular mechanism has not
been completely understood. In addition to coding genes and miRNAs, the contribution of …